Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
GlobeNewswire
Results of Phase 1b/2 in China reinforce global clinical development rationale and plans for LSTA1
BASKING RIDGE, N.J...